The importance of diastolic function to the heart's overall performance has increasingly been recognised over the years and it is now clearly appreciated that left ventricular diastolic dysfunction can lead to the signs and symptoms of heart failure, even where systolic function is well preserved.
The importance of diastolic function to the heart's overall performance has increasingly been recognised over the years and it is now clearly appreciated that left ventricular diastolic dysfunction can lead to the signs and symptoms of heart failure, even where systolic function is well preserved. 1 The sequence can best be understood as follows: first there is impaired filling of the left ventricle. To maintain stroke volume and cardiac output, filling pressure (left atrial pressure) has to rise. This in turn leads to an elevation in both pulmonary venous and pulmonary arterial pressures and hence clinical heart failure.
Diastolic left ventricular dysfunction in man can now readily be detected and assessed by means of contrast angiography, nuclear angiography and Doppler cardiac ultrasound. The latter, in particular, being non-invasive, risk-free and repeatable has proved particularly useful for serial studies such as might be made before and after treatment. 2 There are three stages to normal filling of the left ventricle. 3 In early diastole blood flows down the left atrial-left ventricular pressure gradient and about three-quarters of left ventricular filling then occurs. There may even be a suction effect from the ventricle as it relaxes, although this is still a matter of debate. Following early flow and filling, both come to a virtual standstill-diastasis. The third stage is atrial systole which contributes up to 25% of throughput in normal healthy hearts, but up to 50% in some diseased states.
The shorter diastole then the more these stages overlap, such that even at moderate heart rates, diastasis is virtually abolished and passive and active atrial flow overlap. 4 It is clear, therefore, that studies on diastolic dysfunction are easier to make at slower heart rates.
Doppler echocardiography allows trans-mitral flow to be measured. 5 Thus the early peak diastolic filling rate (or mitral velocity) can be quantified (E wave), as can the same measurements during atrial systole (A wave). From what has been said above, it Correspondence: J Vann Jones Received and accepted 20 July 1997 is evident that in healthy hearts the E/A ratio should be more than one. Other parameters can also be derived from these waves, eg, their duration or their deceleration time. Unlike systolic function, the heart's diastolic function tends to alter with age. It is also readily affected by other influences such as circulating catecholamines, drugs etc.
Using Doppler techniques, diastolic left ventricular dysfunction has been recognised in many cardiac diseases. Three stages in its progression have been described. 3 Initially, there is the stage of impaired relaxation, which clearly will influence the E wave more than the A wave. There is thus an E/A ratio of less than one. This delayed relaxation pattern is seen particularly in patients with left ventricular hypertrophy (LVH) but has been detected in the hearts of hypertensive patients even before there is any evidence of LVH itself. This is in marked contrast to systolic function which in hypertension may even be increased. 6 As diastolic left ventricular dysfunction progresses, the E/A ratio may normalise but the deceleration times become faster (pseudo-normalisation). Finally, in more severe impairment, a restrictive pattern develops with an increase in the E/A ratio due to the high left atrial pressures needed to fill the heart. At this stage the atrial systolic contribution may be minimal (very small A wave) and the E/A ratio more than two.
These parameters have been much studied in the hypertensive population especially in those with LVH. 7 The role that diastolic dysfunction has in the adverse prognosis associated with LVH is unknown, but it would seem reasonable to assume that the two are at least linked. Accordingly, there have been several studies on the possible effect of various antihypertensive agents on the reversal of the diastolic dysfunction associated with LVH. 8, 9 Abnormalities in diastolic left ventricular function do of course occur as a consequence of a raised afterload (high blood pressure), as well as to LVH itself. They are also known to develop before LVH itself has occurred. 10 Several studies, although not all, have shown that reversal of LVH can reverse the parameters of diastolic dysfunction. This can be separated from the antihypertensive effect of these agents.
In this edition of the Journal of Human Hypertension, Molinero et al 11 have studied a group of hypertensive patients in whom they detected echocardiographic evidence of left ventricular diastolic dysfunction, but in whom left ventricular mass index was not increased. They compared the effects of a thiazide/potassium sparing diuretic combination against a sustained release verapamil preparation. Although similar studies have been done using ACE inhibitors, 15 no other antihypertensives have been studied in this way. Clearly the effect on left ventricular diastolic dysfunction is information that we should have for all antihypertensive agents in common use. Molinero et al found that verapamil improved diastolic function, but the diuretic combination did not.
Although interesting, it is important not to draw too many conclusions from this. We do not yet fully understand the prognostic significance of mild degrees of diastolic left ventricular dysfunction, although logic would dictate that any dysfunction cannot be beneficial and its reversal ought to be good. In the study of Molinero et al, 11 the numbers were small and only a few of the indices of diastolic dysfunction were corrected by treatment. Much more information is required before saying one treatment is better in this regard than another.
Of greater importance, however, is confirmation yet again that diastolic dysfunction can be present in hypertensive patients prior to the development of LVH. Perhaps when we order echocardiograms looking for evidence of target organ involvement (LVH), we should widen our request to look for left ventricular diastolic dysfunction. It may be another tool in helping to decide who, or who not, to treat.
